Technology continues to play a crucial role in the life sciences and healthcare sector. From telemedicine and AI-driven diagnostics to robotics in surgery, technological advancement reshapes the industry.
This report is the second edition in our Technology Transformation series. In this publication, we analyse data from a survey of over 500 GCs, senior in-house counsel and risk managers across various sectors. We asked our respondents about their experiences and expectations relating to the use of new technologies, what risks they associate with them and how they intend to deal with these risks.
We extracted and analysed the responses and compared them with the data and observations produced in our first Life Sciences & Healthcare Report. For life sciences and healthcare companies, customer demands, data management and security are the key drivers for the adoption of new technology. The increased usage of AI in this sector is no surprise (in particular in drug discovery, diagnostics and research). However, due to the higher cost and consequences of failure in AI adoption in the sector, concerns about AI-related risks are also more prominent in the survey results.
Download the Technology Transformation Life Sciences and Healthcare sector report now to read about:
- Key drivers for technology adoption in the sector
- Current and future risks
- Measures to deal with technology risks
Global LSHC – Technology Transformation Report 2025
The degree of human oversight on medical diagnoses made using AI tools has to be carefully controlled; where accuracy of AI tools is found to be extremely high and where patients would otherwise not be triaged, there are arguments to reduce the level of human oversight in a controlled manner.
With the sector facing heightened cyber threats, incident response plans are no longer optional. The challenge now lies in operationalising these plans effectively and ensuring they evolve alongside emerging risks like AI and quantum computing.